Neoclease
PrivateLast Round
Accelerator
Sep 1, 2026
Total Funding Raised
$283,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neoclease operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was an Accelerator round in September 2026.
Neoclease is a biotechnology company that develops custom, gene-specific nucleases using generative AI and synthetic biology for precision gene editing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neoclease Comparables
Compare Neoclease with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Profluent Bio | 73% | |
| Arbor Biotechnologies | 73% | |
| Mammoth Biosciences | 71% |
For institutional investors. Book with your work email.
Neoclease Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 1, 2026 | ||||
| Accelerator | Jul 23, 2026 | ||||
| Accelerator | Jul 1, 2025 | ||||
| Grant | Jun 18, 2025 | ||||
| Accelerator | Jun 13, 2025 | ||||
Grant | May 21, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neoclease Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Engine | Accelerator |
| Creative Destruction Lab | Accelerator |
| C10 Labs | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Received funding from MassBio.
- Jul 24, 2026
Monthly visitors grew 675% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Neoclease Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neoclease's valuation, stock price, and market status.
Is Neoclease a public or private company?
Neoclease is a private company.
What is the current stock price of Neoclease?
Neoclease is a private company, so its shares have no public market price. Caplight tracks Neoclease's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neoclease worth (valuation)?
Valuation information for Neoclease is not publicly available.
Can I buy Neoclease stock?
Neoclease shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neoclease's last funding round?
Neoclease's most recent funding round was Accelerator on September 1, 2026.
Who are the main investors in Neoclease?
Key investors in Neoclease include The Engine, Creative Destruction Lab, C10 Labs.
Will Neoclease IPO soon?
No public IPO plans have been announced for Neoclease.
How can I track Neoclease secondary market activity?
Caplight tracks bids, offers, and trades in Neoclease's shares on secondary markets.